24 March 2022 : Clinical Research
Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
Ying Liao1BCE, Changhua Zhu
DOI: 10.12659/MSM.934493
Med Sci Monit 2022; 28:e934493

Figure 3 (A–D) Patients were diagnosed with advanced endometrial cancer by MRI. The figure was edited using Microsoft PowerPoint 2010 (Microsoft, Redmond, WA, USA) from a screenshot from the Medixant, RadiAnt DICOM Viewer (version 2020.2.3) in our institution.